tiprankstipranks
Grace Therapeutics (GRCE)
NASDAQ:GRCE
US Market
GRCE
Grace Therapeutics
RESEARCH TOOLSreports
Want to see GRCE full AI Analyst Report?

Grace Therapeutics (GRCE) Financial Statements

1,203 Followers

Grace Therapeutics Financial Overview

Grace Therapeutics's market cap is currently $38.57M. The company's EPS TTM is $-0.6357; its P/E ratio is -3.73; Grace Therapeutics is scheduled to report earnings on June 18, 2026, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating IncomeC$ -11.08MC$ -23.75MC$ -17.44MC$ -70.54MC$ -19.48M
EBITDAC$ -11.07MC$ -23.74MC$ -15.37MC$ -24.51MC$ -19.17M
Net IncomeC$ -7.79MC$ -13.63MC$ -17.44MC$ -57.39MC$ -12.27M
Balance Sheet
Cash & Short-Term InvestmentsC$ 16.98MC$ 22.13MC$ 23.00MC$ 27.89MC$ 43.66M
Total AssetsC$ 66.65MC$ 71.99MC$ 73.30MC$ 79.12MC$ 128.62M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 485.00KC$ 295.00K
Net DebtC$ -16.98MC$ -22.13MC$ -23.00MC$ -27.39MC$ -30.04M
Total LiabilitiesC$ 2.76MC$ 5.38MC$ 11.56MC$ 11.17MC$ 20.35M
Stockholders' EquityC$ 63.90MC$ 66.61MC$ 61.74MC$ 67.95MC$ 108.27M
Cash Flow
Free Cash FlowC$ -8.87MC$ -14.90MC$ -12.36MC$ -15.93MC$ -17.23M
Operating Cash FlowC$ -8.87MC$ -14.90MC$ -12.33MC$ -15.91MC$ -17.23M
Investing Cash FlowC$ 0.00C$ 0.00C$ 104.00KC$ 13.15MC$ -3.52M
Financing Cash FlowC$ 3.71MC$ 14.03MC$ 7.36MC$ 304.00KC$ 0.00
Currency in CAD

Grace Therapeutics Earnings and Revenue History

Income Statement >

Grace Therapeutics Debt to Assets

Balance Sheet >

Grace Therapeutics Cash Flow

Cash Flow >

Grace Therapeutics Forecast EPS vs Actual EPS

Earnings >